KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to -$202.4 million.

  • Novavax's Net Income towards Common Stockholders fell 6684.17% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 21997.03%. This contributed to the annual value of -$187.5 million for FY2024, which is 6560.04% up from last year.
  • Per Novavax's latest filing, its Net Income towards Common Stockholders stood at -$202.4 million for Q3 2025, which was down 6684.17% from $106.5 million recorded in Q2 2025.
  • Novavax's Net Income towards Common Stockholders' 5-year high stood at $518.6 million during Q1 2025, with a 5-year trough of -$846.3 million in Q4 2021.
  • Over the past 5 years, Novavax's median Net Income towards Common Stockholders value was -$168.6 million (recorded in 2022), while the average stood at -$142.7 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 191082.7% in 2021, then soared by 45150.53% in 2025.
  • Quarter analysis of 5 years shows Novavax's Net Income towards Common Stockholders stood at -$846.3 million in 2021, then skyrocketed by 78.46% to -$182.2 million in 2022, then increased by 2.12% to -$178.4 million in 2023, then surged by 54.58% to -$81.0 million in 2024, then plummeted by 149.76% to -$202.4 million in 2025.
  • Its Net Income towards Common Stockholders was -$202.4 million in Q3 2025, compared to $106.5 million in Q2 2025 and $518.6 million in Q1 2025.